Chaplin, S. (2024). Mirikizumab for moderate to severe ulcerative colitis. Wiley. https://doi.org/10.1002/psb.2131
Style de citation Chicago (17e éd.)Chaplin, Steve. Mirikizumab for Moderate to Severe Ulcerative Colitis. Wiley, 2024. https://doi.org/10.1002/psb.2131.
Style de citation MLA (9e éd.)Chaplin, Steve. Mirikizumab for Moderate to Severe Ulcerative Colitis. Wiley, 2024. https://doi.org/10.1002/psb.2131.
Attention : ces citations peuvent ne pas être correctes à 100%.